IL111767A0 - Tissue plasminogen activator having zymogenic or fibrin specific properties - Google Patents
Tissue plasminogen activator having zymogenic or fibrin specific propertiesInfo
- Publication number
- IL111767A0 IL111767A0 IL11176789A IL11176789A IL111767A0 IL 111767 A0 IL111767 A0 IL 111767A0 IL 11176789 A IL11176789 A IL 11176789A IL 11176789 A IL11176789 A IL 11176789A IL 111767 A0 IL111767 A0 IL 111767A0
- Authority
- IL
- Israel
- Prior art keywords
- zymogenic
- plasminogen activator
- tissue plasminogen
- specific properties
- fibrin specific
- Prior art date
Links
- 102000009123 Fibrin Human genes 0.000 title 1
- 108010073385 Fibrin Proteins 0.000 title 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 title 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 title 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 title 1
- 229950003499 fibrin Drugs 0.000 title 1
- 229960000187 tissue plasminogen activator Drugs 0.000 title 1
- 230000003462 zymogenic effect Effects 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24085688A | 1988-09-02 | 1988-09-02 | |
| US07/384,608 US5108901A (en) | 1988-09-02 | 1989-07-24 | Tissue plasminogen activator having zymogenic or fibrin specific properties |
| IL9130689A IL91306A (en) | 1988-09-02 | 1989-08-14 | Tissue plasminogen variant having amino acid substitution in the protease domain having improved zymogenic or fibrin specific properties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL111767A0 true IL111767A0 (en) | 1995-01-24 |
| IL111767A IL111767A (en) | 1997-04-15 |
Family
ID=27271402
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL109735A IL109735A (en) | 1988-09-02 | 1989-08-14 | Tissue plasminogen activator variants having zymogenic properties having amino acid insertions after position 304 or 305 or at least one residue deletion at positions 297 to 305 |
| IL111767A IL111767A (en) | 1988-09-02 | 1989-08-14 | Method for identifying improved activity tissue plasminogen activator variants with substituted amino acid residue in the protease domain |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL109735A IL109735A (en) | 1988-09-02 | 1989-08-14 | Tissue plasminogen activator variants having zymogenic properties having amino acid insertions after position 304 or 305 or at least one residue deletion at positions 297 to 305 |
Country Status (1)
| Country | Link |
|---|---|
| IL (2) | IL109735A (en) |
-
1989
- 1989-08-14 IL IL109735A patent/IL109735A/en active IP Right Grant
- 1989-08-14 IL IL111767A patent/IL111767A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL111767A (en) | 1997-04-15 |
| IL109735A0 (en) | 1994-08-26 |
| IL109735A (en) | 1997-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ215660A (en) | Tissue plasminogen activator modified in the growth factor domain | |
| AU6806487A (en) | Tissue plasminogen activator | |
| AU3838189A (en) | Tissue plasminogen activator analogues having improved activity | |
| AU2778889A (en) | Fibrin selective two-chain plasminogen activator | |
| ZA886401B (en) | Modified plasminogen activators | |
| IL111767A0 (en) | Tissue plasminogen activator having zymogenic or fibrin specific properties | |
| GB8901422D0 (en) | New tissue plasminogen activator | |
| GB8815245D0 (en) | New tissue plasminogen activator | |
| GB8826692D0 (en) | Tissue plasminogen activator | |
| GB8815247D0 (en) | New tissue plasminogen activator | |
| GB8815246D0 (en) | New tissue plasminogen activator | |
| EP0337817A3 (en) | Plasminogen activator and thrombolytic agent | |
| IE870208L (en) | Modified tissue plasminogen activator | |
| ZA884012B (en) | Tissue plasminogen activator analogs having modified growth factor domains | |
| PT87641A (en) | PROCESS FOR ISOLATE AND PURIFY CONCERNING A TISSUE PLASMINOGEN ACTIVATOR | |
| GB9000629D0 (en) | Tissue plasminogen activator | |
| AU608232C (en) | Modified tissue plasminogen activator | |
| GB8725052D0 (en) | Tissue plasminogen activator | |
| GB8718298D0 (en) | Tissue plasminogen activator | |
| GB8726683D0 (en) | Tissue plasminogen activator | |
| IE861388L (en) | Tissue plasminogen activator | |
| IE882534L (en) | Peg complex of tissue plasminogen activator | |
| AU7554687A (en) | Modified tissue plasminogen activator | |
| IE890741L (en) | Tris-kringle plasminogen activator with k2 insert | |
| NZ223291A (en) | Modified tissue-type plasminogen activator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees | ||
| KB | Patent renewed | ||
| KB | Patent renewed |